Epidermal-skin-test 1000 (EST-1000) - A new reconstructed epidermis for in vitro skin corrosivity testing
Epidermal-skin-test 1000 (EST-1000) - A new reconstructed epidermis for in vitro skin corrosivity testing
复制标题
DOI:
10.1016/j.tiv.2005.06.010
复制
发表时间:
2005-10-01
影响因子:
3.2
通讯作者:
Fuchs, HW
中科院分区:
文献类型:
--
作者:
Hoffmann, J;Heisler, E;Fuchs, HW
The determination of a possible corrosive or irritative potential of certain products and ingredients is necessary for their classification and labeling requirements. Reconstructed skin as a model system provides fundamental advantages to single cell culture testing and leads to promising results as shown by different validation studies (for review: Fentem, J.H., Botham, P.A., 2002. ECVAM's activities in validating alternative tests for skin corrosion and irritation. ATLA 30(Suppl. 2), 61-67). In this study we introduce our new reconstructed epidermis "Epidermal-Skin-Test" (EST-1000). This fully grown epidermis consists of proliferating as well as differentiating keratinocytes. EST-1000 shows a high comparability to normal human skin as shown by histological and immuno-histochemical data. Characteristic markers (KI-67, CK 1/10/5/14, transglutaminase, collagen IV, involucrin, beta 1 integrin) can be identified easily. The main focus of this work was to characterize EST-1000 especially with respect to its barrier function by testing several substances of known corrosive potential. Skin corrosion was detected by the cytotoxic effect of the substances on a reconstructed epidermis after short-term application to the stratum corneum. The effect was determined by standard MTT assay and accompanying histological analysis. Hence EST-1000 shows a very high predictive potential and closes the gap between animal testing and the established full-thickness model Advanced-Skin-Test 2000 (AST-2000) (Noll, M., Merkle, M.-L., Kandsberger, M., Matthes, T., Fuchs, H., Graeve, T., 1999. Reconstructed human skin (AST-2000) as a tool for pharmaco-toxicology. ATLA 27, 302). (c) 2005 Elsevier Ltd. All rights reserved.